Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes
Status:
Recruiting
Trial end date:
2021-08-31
Target enrollment:
Participant gender:
Summary
To determine whether inhaled Yabro protects against progression of COVID19-induced
respiratory failure preventing the passage to non-invasive ventilation (NIV) and promotes
recovery from COVID19 lung disease in hospitalized patients.
Phase:
Phase 2
Details
Lead Sponsor:
Campus Bio-Medico University
Collaborator:
National Institute of Environmental Health Sciences (NIEHS)